nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfaphenazole—CYP2B6—Thiotepa—urinary bladder cancer	0.306	0.355	CbGbCtD
Sulfaphenazole—CYP2A6—Fluorouracil—urinary bladder cancer	0.152	0.177	CbGbCtD
Sulfaphenazole—CYP2B6—Cisplatin—urinary bladder cancer	0.0843	0.0979	CbGbCtD
Sulfaphenazole—CYP2C8—Fluorouracil—urinary bladder cancer	0.0752	0.0873	CbGbCtD
Sulfaphenazole—CYP2C8—Etoposide—urinary bladder cancer	0.0627	0.0729	CbGbCtD
Sulfaphenazole—CYP2B6—Doxorubicin—urinary bladder cancer	0.0565	0.0656	CbGbCtD
Sulfaphenazole—CYP2C9—Fluorouracil—urinary bladder cancer	0.0524	0.0609	CbGbCtD
Sulfaphenazole—CYP2C9—Cisplatin—urinary bladder cancer	0.0445	0.0517	CbGbCtD
Sulfaphenazole—CYP2D6—Doxorubicin—urinary bladder cancer	0.0273	0.0317	CbGbCtD
Sulfaphenazole—Sulfamethoxazole—NAT1—urinary bladder cancer	0.00706	0.488	CrCbGaD
Sulfaphenazole—Sulfamethoxazole—NAT2—urinary bladder cancer	0.00222	0.154	CrCbGaD
Sulfaphenazole—Dapsone—NAT2—urinary bladder cancer	0.00174	0.12	CrCbGaD
Sulfaphenazole—Sulfasalazine—PPARG—urinary bladder cancer	0.00113	0.0779	CrCbGaD
Sulfaphenazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000913	0.00757	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000909	0.00754	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000908	0.00754	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000905	0.00751	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000901	0.00747	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000895	0.00742	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.00088	0.0073	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—urinary bladder cancer	0.000875	0.00726	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—NAT1—urinary bladder cancer	0.000858	0.00712	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTO2—urinary bladder cancer	0.000858	0.00712	CbGpPWpGaD
Sulfaphenazole—Dapsone—MPO—urinary bladder cancer	0.000822	0.0569	CrCbGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000818	0.00679	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000785	0.00651	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000769	0.00638	CbGpPWpGaD
Sulfaphenazole—CYP2C9—urine—urinary bladder cancer	0.00075	0.189	CbGeAlD
Sulfaphenazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000746	0.00619	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00074	0.00614	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000737	0.00611	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000731	0.00606	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000721	0.00598	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000707	0.00586	CbGpPWpGaD
Sulfaphenazole—Celecoxib—PTGS2—urinary bladder cancer	0.000702	0.0486	CrCbGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTO2—urinary bladder cancer	0.000693	0.00574	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—NAT1—urinary bladder cancer	0.000693	0.00574	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00069	0.00572	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000683	0.00567	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000633	0.00525	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000625	0.00518	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTZ1—urinary bladder cancer	0.000618	0.00513	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00061	0.00506	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTO2—urinary bladder cancer	0.000586	0.00486	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—NAT1—urinary bladder cancer	0.000586	0.00486	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000578	0.0048	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—CYP4B1—urinary bladder cancer	0.00057	0.00473	CbGpPWpGaD
Sulfaphenazole—CYP2D6—urine—urinary bladder cancer	0.000563	0.142	CbGeAlD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000562	0.00467	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000562	0.00466	CbGpPWpGaD
Sulfaphenazole—CYP2A6—prostate gland—urinary bladder cancer	0.00054	0.136	CbGeAlD
Sulfaphenazole—CYP2C8—Biological oxidations—UGT2B7—urinary bladder cancer	0.000536	0.00445	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000529	0.00439	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000508	0.00421	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.000503	0.00418	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000501	0.00415	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000496	0.00412	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000491	0.00408	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—CYP4B1—urinary bladder cancer	0.000483	0.00401	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—NAT1—urinary bladder cancer	0.000481	0.00399	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTO2—urinary bladder cancer	0.000481	0.00399	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000477	0.00396	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000477	0.00396	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000476	0.00395	CbGpPWpGaD
Sulfaphenazole—Sulfasalazine—PTGS2—urinary bladder cancer	0.000475	0.0329	CrCbGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000475	0.00394	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000471	0.0039	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—NAT2—urinary bladder cancer	0.00047	0.0039	CbGpPWpGaD
Sulfaphenazole—CYP2A6—seminal vesicle—urinary bladder cancer	0.000457	0.115	CbGeAlD
Sulfaphenazole—CYP2D6—Biological oxidations—UGT2B7—urinary bladder cancer	0.00044	0.00365	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000436	0.00362	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000434	0.0036	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00043	0.00357	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000408	0.00339	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000396	0.00329	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000393	0.00326	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000391	0.00324	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000388	0.00321	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—NAT2—urinary bladder cancer	0.000379	0.00315	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—HPGDS—urinary bladder cancer	0.000376	0.00312	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000374	0.0031	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTT1—urinary bladder cancer	0.000365	0.00302	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—NQO1—urinary bladder cancer	0.000346	0.00287	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000339	0.00281	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000332	0.00276	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—NAT2—urinary bladder cancer	0.000321	0.00266	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000317	0.00263	CbGpPWpGaD
Sulfaphenazole—Dapsone—PTGS2—urinary bladder cancer	0.000308	0.0213	CrCbGaD
Sulfaphenazole—CYP2B6—Biological oxidations—HPGDS—urinary bladder cancer	0.000303	0.00252	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	0.000294	0.00244	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000292	0.00242	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—GSTP1—urinary bladder cancer	0.000288	0.00239	CbGpPWpGaD
Sulfaphenazole—CYP2A6—vagina—urinary bladder cancer	0.000267	0.0673	CbGeAlD
Sulfaphenazole—CYP2A6—NRF2 pathway—GSTM1—urinary bladder cancer	0.000265	0.0022	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000264	0.00219	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000261	0.00217	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00026	0.00216	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000258	0.00214	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000257	0.00213	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000253	0.0021	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.000249	0.00207	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00024	0.00199	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTM1—urinary bladder cancer	0.000232	0.00193	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000211	0.00175	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000209	0.00173	CbGpPWpGaD
Sulfaphenazole—CYP2C8—renal system—urinary bladder cancer	0.000207	0.0522	CbGeAlD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000205	0.0017	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.000204	0.00169	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000203	0.00168	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000201	0.00167	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000196	0.00162	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.000187	0.00155	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000185	0.00154	CbGpPWpGaD
Sulfaphenazole—CYP2B6—renal system—urinary bladder cancer	0.000185	0.0468	CbGeAlD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000185	0.00153	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	0.000173	0.00143	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00017	0.00141	CbGpPWpGaD
Sulfaphenazole—CYP2C8—female reproductive system—urinary bladder cancer	0.000165	0.0418	CbGeAlD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	0.000159	0.00132	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000156	0.0013	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	0.000155	0.00128	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000151	0.00125	CbGpPWpGaD
Sulfaphenazole—CYP2C8—vagina—urinary bladder cancer	0.00015	0.0378	CbGeAlD
Sulfaphenazole—CYP2B6—female reproductive system—urinary bladder cancer	0.000148	0.0375	CbGeAlD
Sulfaphenazole—CYP2C9—female reproductive system—urinary bladder cancer	0.000147	0.0371	CbGeAlD
Sulfaphenazole—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	0.000147	0.00122	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NAT1—urinary bladder cancer	0.000147	0.00122	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000142	0.00118	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000141	0.00117	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00014	0.00116	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000139	0.00115	CbGpPWpGaD
Sulfaphenazole—CYP2D6—renal system—urinary bladder cancer	0.000138	0.0348	CbGeAlD
Sulfaphenazole—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	0.000134	0.00111	CbGpPWpGaD
Sulfaphenazole—CYP2B6—vagina—urinary bladder cancer	0.000134	0.0339	CbGeAlD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.00013	0.00108	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000129	0.00107	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000128	0.00107	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000127	0.00106	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	0.000125	0.00104	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	0.000121	0.001	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	0.000118	0.000982	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NAT1—urinary bladder cancer	0.000118	0.000982	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	0.000114	0.000947	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	0.000111	0.000923	CbGpPWpGaD
Sulfaphenazole—CYP2D6—female reproductive system—urinary bladder cancer	0.00011	0.0278	CbGeAlD
Sulfaphenazole—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	0.000108	0.000899	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	0.000106	0.000877	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	0.0001	0.000832	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NAT1—urinary bladder cancer	0.0001	0.000832	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.86e-05	0.000818	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	9.75e-05	0.000809	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	9.21e-05	0.000764	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	9.17e-05	0.000761	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	8.98e-05	0.000745	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—TYMP—urinary bladder cancer	8.89e-05	0.000738	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	8.68e-05	0.00072	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	8.61e-05	0.000714	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	8.26e-05	0.000685	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	8.23e-05	0.000683	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NAT1—urinary bladder cancer	8.23e-05	0.000683	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	8.16e-05	0.000677	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NAT1—urinary bladder cancer	8.16e-05	0.000677	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NAT2—urinary bladder cancer	8.04e-05	0.000667	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.03e-05	0.000666	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	7.8e-05	0.000647	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	7.6e-05	0.00063	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	7.53e-05	0.000625	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	7.46e-05	0.000619	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—TYMP—urinary bladder cancer	7.18e-05	0.000595	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—RRM2—urinary bladder cancer	6.94e-05	0.000576	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	6.78e-05	0.000562	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	6.72e-05	0.000557	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NAT2—urinary bladder cancer	6.49e-05	0.000538	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	6.43e-05	0.000533	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—ENO2—urinary bladder cancer	6.43e-05	0.000533	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	6.4e-05	0.000531	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	6.35e-05	0.000526	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	6.24e-05	0.000517	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	6.24e-05	0.000517	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	6.18e-05	0.000513	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.09e-05	0.000505	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—TYMP—urinary bladder cancer	6.07e-05	0.000504	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.83e-05	0.000484	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—RRM2—urinary bladder cancer	5.6e-05	0.000465	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NAT2—urinary bladder cancer	5.49e-05	0.000456	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	5.19e-05	0.00043	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—ENO2—urinary bladder cancer	5.19e-05	0.00043	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NQO1—urinary bladder cancer	5.18e-05	0.00043	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	5.03e-05	0.000417	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.99e-05	0.000414	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.96e-05	0.000411	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.94e-05	0.00041	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.75e-05	0.000394	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—RRM2—urinary bladder cancer	4.74e-05	0.000393	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.51e-05	0.000374	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.47e-05	0.000371	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.39e-05	0.000364	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.39e-05	0.000364	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.37e-05	0.000362	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	4.32e-05	0.000359	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	4.26e-05	0.000353	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.19e-05	0.000348	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NQO1—urinary bladder cancer	4.18e-05	0.000347	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—TYMS—urinary bladder cancer	4.02e-05	0.000333	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	3.97e-05	0.00033	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	3.97e-05	0.00033	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.89e-05	0.000323	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.86e-05	0.00032	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GPX1—urinary bladder cancer	3.8e-05	0.000316	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	3.73e-05	0.00031	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.61e-05	0.000299	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.61e-05	0.000299	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.57e-05	0.000297	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.57e-05	0.000297	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.55e-05	0.000295	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.54e-05	0.000294	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	3.51e-05	0.000291	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.5e-05	0.00029	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	3.49e-05	0.000289	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.47e-05	0.000288	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.43e-05	0.000285	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.41e-05	0.000283	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—TYMS—urinary bladder cancer	3.24e-05	0.000269	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	3.21e-05	0.000266	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	3.21e-05	0.000266	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GPX1—urinary bladder cancer	3.07e-05	0.000255	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	3.01e-05	0.00025	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3e-05	0.000248	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.95e-05	0.000245	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.91e-05	0.000241	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.88e-05	0.000239	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.86e-05	0.000237	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PPARG—urinary bladder cancer	2.85e-05	0.000236	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.83e-05	0.000235	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.8e-05	0.000232	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.75e-05	0.000228	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	2.73e-05	0.000227	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.71e-05	0.000225	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.71e-05	0.000225	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.6e-05	0.000216	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.55e-05	0.000212	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.44e-05	0.000202	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.42e-05	0.000201	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.4e-05	0.000199	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.4e-05	0.000199	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.33e-05	0.000193	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PPARG—urinary bladder cancer	2.3e-05	0.000191	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.25e-05	0.000187	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	2.24e-05	0.000186	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.23e-05	0.000185	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.23e-05	0.000185	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.23e-05	0.000185	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.21e-05	0.000183	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.21e-05	0.000183	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	2.21e-05	0.000183	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.13e-05	0.000177	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.11e-05	0.000175	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000174	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.08e-05	0.000172	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.97e-05	0.000163	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.95e-05	0.000162	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.95e-05	0.000162	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.94e-05	0.000161	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.87e-05	0.000155	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.86e-05	0.000154	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.81e-05	0.00015	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.6e-05	0.000132	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.58e-05	0.000131	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.58e-05	0.000131	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000127	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.53e-05	0.000127	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.52e-05	0.000126	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.5e-05	0.000125	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.33e-05	0.000111	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.27e-05	0.000106	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	0.000104	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	0.000103	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.1e-05	9.08e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.09e-05	9.01e-05	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.04e-05	8.66e-05	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.04e-05	8.59e-05	CbGpPWpGaD
